There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K39/395
Jump to navigation
Jump to search
Pages in category "A61K39/395"
The following 16 pages are in this category, out of 16 total.
1
- 18193062. CANCER TREATMENT COMBINATIONS simplified abstract (The Regents of the University of California)
- 18234229. METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18250727. SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18364185. ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF simplified abstract (Genentech, Inc.)
- 18517327. BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE simplified abstract (Genentech, Inc.)
2
- 20240010707. De-immunized Factor VIII Molecule and Pharmaceutical Compositions Comprising the Same simplified abstract (Biotest AG)
- 20240016787. METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES simplified abstract (RDiscovery, LLC)
- 20240043503. COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY simplified abstract (ADMA BIOMANUFACTURING, LLC)
B
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on March 7th, 2024